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Abstract
Volatile organic compounds (VOCs)measured from exhaled breath have great promise for the
diagnosis of bacterial infections. However, determining human ormicrobial origin of VOCs detected
in breath remains a great challenge. For example, themicrobial fermentation product 2,3-
butanedionewas recently found in the breath of Cystic Fibrosis (CF) patients; parallel culture-
independentmetagenomic sequencing of the same samples revealed that Streptococcus andRothia spp.
have the genetic capacity to produce 2,3-butanedione. To investigate whether the genetic capacity
found inmetagenomes translates to bacterial production of aVOCof interest such as 2,3-
butanedione, we fed stable isotopes to three bacterial strains isolated frompatients: two gram-positive
bacteria,Rothiamucilaginosa and Streptococcus salivarius, and a dominant opportunistic gram-
negative pathogen, Pseudomonas aeruginosa. Culture headspaces were collected and analyzed using a
gas chromatographic system to quantify the abundance of VOCs of interest;mass spectroscopywas
used to determinewhether the stable isotope label had been incorporated. Our results show thatR.
mucilaginosa and S. salivarius consumedD-Glucose-13C6 to produce labeled 2,3-butanedione.R.
mucilaginosa and S. salivarius also produced labeled acetaldehyde and ethanol when grownwith 2H2O.
Additionally, we ﬁnd thatP. aeruginosa growth and dimethyl sulﬁde production are increasedwhen
exposed to lactic acid in culture. These results highlight the importance VOCs produced byP.
aeruginosa, R.mucilaginosa, and S. salivarius as nutrients and signals inmicrobial communities, and as
potential biomarkers in a CF infection.
Introduction
Breath metabolites have incredible potential to serve
as non-invasive diagnostics of bacterial infection and
other diseases, but the origins of the metabolites are
often unknown. Microbes contribute signiﬁcantly to
the complex mix of molecules present in the human
body. An average human likely contains >200 000
metabolites, and half ormore of them are produced by
or altered by the microbes that reside in and on
humans (Wikoff et al 2009, Dorrestein et al 2014,
Sharon et al 2014). Furthermore, most of the genes
that distinguish one person from another are encoded
by the microbial community that inhabits each
person; human-associated microbes encode at least an
order of magnitude more genes than the human
genome (McFall-Ngai et al 2013). A very early attempt
to proﬁle breath and urine metabolites by Linus
Pauling at Caltech in 1971 showed that starving the gut
microbes led to more consistent breath and urine
proﬁles across study participants (Pauling et al 1971).
More recent studies have sampled breath VOCs to
diagnose or detect bacterial infections in pneumonia
(Fijten et al 2015) and tuberculosis (Phillips et al 2010).
Some of the metabolites produced by human-
associated microbes are volatile, have the capacity to
travel and affect the physiology of neighboring micro-
bial and human cells, and can be captured by breath
sampling (Létoffé et al 2014, Audrain et al 2015). For
example, 2,3-butanedione was detected in the breath
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of Cystic Fibrosis (CF) patients (Whiteson et al 2014).
One challenge in identifying the cellular origin of vola-
tile organic compounds (VOCs) is determining whe-
ther the metabolites are produced by microbial or
human cells. Humans and bacteria share several fun-
damental pathways and have the ability to produce
many of the same volatile molecules, such as isoprene
and acetone, the twomost abundant VOCs detected in
breath (Fenske and Paulson 1999, Miekisch et al 2004,
Thorn and Greenman 2012). In the case of 2,3-buta-
nedione, a subset of microbes encode the enzymes
from this fermentation pathway, however 2,3-butane-
dione is not known to be a product of humanmetabo-
lism. Parallel metagenomic sequencing from CF
patients with 2,3-butanedione in their breath showed
Streptococcus andRothia spp. contain the acetoin path-
way genes leading to the production of 2,3-butane-
dione (Whiteson et al 2014). A similar companion
study also produced in this special issue of the Journal
of Breath Research shows the taxonomy of microbial
genes responsible for the production of acetaldehyde
and ethanol (Bos et al 2016). To determine whether
2,3-butanedione and other volatile molecules of inter-
est such as acetaldehyde and ethanol are actively pro-
duced by bacterial isolates from CF patients, we
employed the use of labeled stable isotopes fed to
in vitro cultures to track bacterialmetabolism.
This study focuses on several bacterial isolates
from CF patients that are often found in the airways
when the natural lung clearance mechanisms are
impaired. Therefore, the molecules that are produced
by these bacteria are potentially relevant for CF,
chronic obstructive pulmonary disorder, and pneu-
monia. CF patients’ lungs are chronically infected with
opportunistic pathogens that signiﬁcantly alter the
health and physiology of the patient. Different types of
infections can lead to varying patient outcomes (Hau-
ser et al 2011, Ahlgren et al 2015). Among the most
dominant bacteria are Pseudomonas aeruginosa,
Burkholderia species, Staphylococcus aureus, Steno-
trophomonas maltophilia, and Streptococcus pneumo-
niae (table 1). Rothia mucilaginosa has also been found
to be a dominant strain in culture-independent studies
of CF airway microbial communities (Lim et al 2013),
and is highly abundant in CF sputum samples (Blainey
et al 2012, Fodor et al 2012, Paganin et al 2015).
Our goal was to track microbial production of
VOCs in clinically relevant CF bacteria. Speciﬁcally,
we were interested in P. aeruginosa, R. mucilaginosa,
and Streptococcus salivarius. P. aeruginosa is a wide-
spread opportunistic pathogen in CF which becomes
more dominant through time in decades-long chronic
CF infections. The recent detection of 2,3-butane-
dione in the breath of CF patients, alongwith the genes
necessary for acetoin metabolism from metagenomic
sequencing of the same samples (Whiteson et al 2014),
motivated us to see if we could verify that CF isolates
are indeed producing 2,3-butanedione. Analysis of
culture-independent metagenomic sequence reads
from CF sputum showed that R. mucilaginosa and a
variety of Streptococcus spp. encode genes involved in
the production of 2,3-butanedione (Whiteson
et al 2014), which induces virulence in P. aeruginosa
(Venkataraman et al 2011, 2014,Whiteson et al 2014)
and has also been found to be present in the breath of
CF patients (Whiteson et al 2014). R. mucilaginosa is
an abundant and understudied bacteria common in all
human oral-microbial communities, including CF
sputum, and it is known to produce the toxic volatile
acetaldehyde (table 1) (Moritani et al 2015). Strepto-
coccus spp. are also common in all human oral micro-
bial communities. A large fraction of themetagenomic
reads thatmap to the 2,3-butanedione pathway—25%
to 85%—originated from Streptococcus (Whiteson
et al 2014). The sequences from CF sputum mapped
equally well to several strains of Streptococcus spp.,
including S. parasanguinus, S. salivarius and S. pneu-
monia. We included a strain of S. salivarius cultured
from a CF patient which is capable of producing 2,3-
butanedione based on genome sequence data.
To track VOCs produced by microbial metabo-
lism, we used stable isotopes (D-Glucose-13C6 and
2H2O), sampled headspaces of in vitro cultures, and
analyzed these headspace samples using a gas chroma-
tography multi column/detector system. Although
metagenomic evidence suggests that Streptococcus spp.
Table 1.Ten topmicrobes in theCF airway and some of theVOCs they produce.
Microbe VOCs Supporting literature
Pseudomonas aeruginosa 2-butanone, 2-aminoacetophenone, dimethylsulﬁde, and
hydrogen cyanide
Preti et al 2009, Scott-Thomas
et al 2010, Smith et al 2013,
Streptococcus pneumoniae Benzaldehyde, benzylalcohol, acetic acid, and acetaldehyde Preti et al 2009, Filipiak et al 2012
Staphylococcus aureus Isovaleric acid, 2-methylbutyric acid, and isobutyric acid Preti et al 2009
Rothiamucilaginosa Acetaldehyde Moritani et al 2015
Veillonella Propionic acid, acetic acid, and isovaleric acid Dumont et al 1978
Prevotella Acetic and succinic acids Downes et al 2007
Haemophilus inﬂuenza Indole, benzaldehyde, acetic acid, and benzylalcohol Preti et al 2009, Filipiak et al 2012
Stenotrophomonasmaltophilia Methylpyrazine, dimethylpyrazine, acetophenone, and
caprolactam
Preti et al 2009
Burkholderia spp. Acetic acid, dimethyl disulﬁde, andmethylcyclohexane Tenorio-Salgado et al 2013
Granulicatella N/A N/A
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and R. mucilaginosa may produce 2,3-butanedione
(Whiteson et al 2014), this study used stable isotopes to
conﬁrm its production by CF isolates. We also set up
cultures of a clinical isolate of P. aeruginosa to study
VOC production with and without 2,3-butanediol
and other physiologically relevant products of S. sali-
varius and R. mucilaginosa. Future investigation for
optimal P. aeruginosa growth conditions in super-
natants from other bacteria is one of our goals in
understanding how P. aeruginosa is affected by the
neighboringCF community.
The airways of people with CF have a lower
pH than healthy airways, and immediately prior to a
pulmonary exacerbation event, the pH drops even
lower (Tate et al 2002, Ojoo et al 2005, Pezzulo
et al 2012, Quinn et al 2015). To investigate the effect
of low pH on our clinical isolates, our experimental
conditions also involved the use of lactic acid or buffer
to adjust the media pH. In summary, results show that
levels of 2,3-butanedione, acetaldehyde, and dimethyl
sulﬁde are increased when the pH is decreased and
these signatures can be used to distinguish the meta-
bolisms of P. aeruginosa, R. mucilaginosa, and S.
salivarius.
Materials andmethods
Bacterial strains and growth conditions
The bacterial strains chosen for this study were
isolated from CF patients at the UCSD Adult CF
Clinic: Pseudomonas aeruginosa PaFLR01, Rothia
mucilaginosa RmFLR01, and Streptococcus salivarius
SsFLR02. Strains were grown at 37 °C for 24 h in
Todd Hewitt (TH) broth (BD Bacto, Fisher Scien-
tiﬁc). From the 24 h cultures, triplicate OD500 0.05
cultures were started in TH broth with 30 mM
D-Glucose-13C6 (Sigma-Aldrich andCambridge Iso-
tope Laboratory), unless otherwise noted. Some
conditions involve the addition of 30% 2H2O
(Sigma-Aldrich) or 100 mM pH 6.5 potassium phos-
phate buffer (Fisher Scientiﬁc). We used OD500 to
measure cell densities, instead of OD600 that is
traditionally used, because P. aeruginosa strain
PaFLR01 produces pyocyanin, a colorful phenazine
that absorbs at 691 nm.
P. aeruginosa pyocyaninmeasurement
At the end of each experiment, P. aeruginosa cultures
were centrifuged to pellet cells and supernatants were
collected to read absorbance measurements at 691 nm
with a spectrophotometer.
Headspace gas capture and gas chromatography
A modiﬁed bioreactor and a gas chromatographic
(GC) system were used for headspace gas collection
and VOC analysis (Colman et al 2001, Umber
et al 2013). In particular, replicates of three individual
glass culture tubes were placed in the bulb of the
bioreactor (ﬁgure 1(a)) and, in order to replace any
laboratory air, the reactor was ﬂushed for 6 min at
1.5 l min−1 with ultra clean air collected at 10 000 feet
at the Crooked Creek Research station in White
Mountain (California). After ﬂushing, the bioreactor
was incubated at 37 °C for 48 h statically and the
headspace was collected and analyzed using a GC
system as described in previous works (Colman
et al 2001, Shin et al 2009, Umber et al 2013,Whiteson
et al 2014). Brieﬂy, headspace sample was cryogeni-
cally pre-concentrated in a stainless steel loop ﬁlled
with glass beads. The sample was re-vaporized using
Figure 1.Experimental design. (a)The bulb that holds triplicate glass vials for each experimental condition. The duration of the
experiment is 48 h and cultures are kept static. (b)The volume in each glass vial is 2 ml. Panel 1 is a simpliﬁed representation of our
experiment controls. There are threemedia controls: ToddHewitt (TH) brothwith 30% 2H20, THwith 30 mMD-Glucose-
13C6, and
THwith 30% 2H20 and 30 mMD-Glucose-
13C6. For the Pa control, we grewP. aeruginosa in THwith 30%
2H20. For the Rmand Ss
controls, we grew each strain in THwith 30% 2H20 and 30 mMD-Glucose-
13C6. Panel II is an experiment set wherewe cultured P.
aeruginosawith threemetabolites: 2,3-butanediol, lactic acid, and pyruvate.When P. aeruginosawas culturedwith 2,3-butanediol and
lactic acid, TH and 30% 2H20mediawas used.With pyruvate, TH andD-Glucose-
13C6was used asmedia. Panel III represents the
supernatants fromR.mucilaginosa and S. salivarius.We have supernatants fromunbuffered and buffered pH6.5 THmedia.
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hot water (at approximately 80 °C) and split into ﬁve
streams directed to a multi-column/detector GC
system (all Hewlett Packard 6890) using UHP helium
as carrier gas. The system consists of three Hewlett-
Packard 6890 GC units. The ﬁrst GC is equipped with
two different column combinations output to an
electron capture detector (ECD) and an FID; the
second GC is output to an FID; and the third GC is
equipped with two different column combinations
and output to a quadrupole mass spectrometer
detector working in selected ion monitoring (SIM)
mode, and an ECD. The MSD is set to operate in SIM
mode and scanmode simultaneously.
The different VOCs are expressed in part per tril-
lion by volume. The average from the triplicate sam-
ples and a one-tailed student’s t-test was used to
identify VOCs that were signiﬁcantly elevated com-
pared to themedia control.
Genome annotation
P. aeruginosa and S. salivarius genomes were
sequenced on the Illumina MiSeq platform at San
Diego State University. R. mucilaginosawas sequenced
on the Illumina MiSeq platform at microbesNG at the
University of Birmingham. All sequenced genomes
were uploaded onto RAST for annotation (Aziz
et al 2008).
Experimental design
Figure 1 displays the conditions of the experiment. All
conditions were tested as biological triplicates in 2 ml
volumes for 48 h, static. The media control included
three conditions: TH broth with 2H2O, TH broth with
D-Glucose-13C6, and TH with both
2H2O and
D-Glucose-13C6. The P. aeruginosa control included
two conditions: P. aeruginosa grown in TH with 2H2O
or TH with D-Glucose-13C6 and pyruvate. The R.
mucilaginosa and S. salivarius controls included each
strain grown in TH with 2H2O and D-Glucose-
13C6
(Panel I). P. aeruginosa was cultured in TH with the
addition three metabolites: 20 mM 2,3-butanedione,
20 mM lactic acid, and 30 mM pyruvate (Panel II).
We collected R. mucilaginosa and S. salivarius super-
natants to perform cross-feeding experiments with P.
aeruginosa, but P. aeruginosa did not grow. Therefore,
we excluded that portion of the data set, but still
kept the supernatants (Panel III) because the strains
were cultured with a single labeled isotope,
D-Glucose-13C6.
CFC-11 is consistent across all samples
Trichloroﬂuoromethane (CFC-11) is a VOC we do
not expect to see produced by our strains and is
constant across all samples (supplementary ﬁgure 2).
Therefore, CFC-11 is a good negative control for the
GC system.
Results and discussion
Production of 2,3-butanedione, acetaldehyde, and
ethanol
2,3-butanedione, acetaldehyde, and ethanol are fer-
mentation products derived from pyruvate metabo-
lism (ﬁgure 2). As part of glycolysis, glucose is
converted to pyruvate. Following pyruvate metabo-
lism, pyruvate can either be converted to acetolactate
or acetaldehyde by the enzymes acetolactate synthase
(BudB, E.C. 2.2.1.6) or pyruvate decarboxylase (Pdc,
E.C. 4.1.1.1), respectively (ﬁgure 2). Acetolactate is
then broken down to 2,3-butanedione and acetoin by
the enzymeBudA (E.C. 4.1.1.5;ﬁgure 2). Acetaldehyde
can be converted to ethanol by alcohol dehydrogenase
(ADH, E.C. 1.1.1.1; ﬁgure 2); the reaction is reversible.
By using D-Glucose-13C6, we expect to see labeled
VOCs derived from pyruvate metabolism, speciﬁcally
2,3-butanedione, acetaldehyde, and ethanol. We
expect R. mucilaginosa and S. salivarius to consume
glucose, but glucose is not a preferred carbon source
for P. aeruginosa, so we included 2H2O in our
experiments in order to track active P. aeruginosa
metabolism.
When R. mucilaginosa and S. salivarius consume
D-Glucose-13C6, our data show that
13C was incorpo-
rated into 2,3-butanedione. We attribute labeled 2,3-
butanedione to R. mucilaginosa and S. salivariusmeta-
bolism because while there was unlabeled 2,3-butane-
dione in the media and P. aeruginosa controls, 13C was
only incorporated when D-Glucose-13C6 was metabo-
lized by R. mucilaginosa, and S. salivarius (ﬁgure 3(a)).
Genetic evidence also supports these ﬁndings. P. aeru-
ginosa, R. mucilaginosa, and S. salivarius have the
genetic capability to convert pyruvate to acetolactate
by BudB (E.C. 2.2.1.6) (ﬁgure 2). Only R. mucilaginosa
and S. salivarius have the genetic capacity to convert
acetolactate to 2,3-butanedione and acetoin through
BudA (E.C. 4.1.1.5) (ﬁgure 2).
Through fermentation, pyruvate can be converted
to acetaldehyde by pyruvate decarboxylase (Pdc, E.C.
4.1.1.1; ﬁgure 2). An example of an in vitro study of
milk fermentation demonstrated through use of
labeled isotopes that Streptococcus thermophilus was
able to convert 13C-glucose to acetaldehyde (Ott
et al 2000). Surprisingly, while the CF isolates of R.
mucilaginosa and S. salivarius produced acetaldehyde
and ethanol, the cultures grown with D-Glucose-13C6
did not lead to production of 13C-labeled acetaldehyde
or ethanol (shaded areas of ﬁgures 3(b) and (c)).When
R. mucilaginosa and S. salivarius are cultured in media
with 2H2O, both acetaldehyde and ethanol are labeled
(unshaded areas of ﬁgures 3(b) and (c)). P. aeruginosa
cultures did not produce any of the fermentation pro-
ducts shown in ﬁgure 3 in levels higher than the media
controls. Labeled acetaldehyde was also detected in the
media control when 2H2O was present. We expected
deuterium incorporation into acetaldehyde to depend
on bacterial enzymes. However, acetaldehyde is a weak
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acid, and in the presence of base in the media the deu-
terium exchange with the alpha carbons of acet-
aldehyde could occur.
Acetaldehyde production may rely on acetate,
acetyl-CoA, pyruvate, L-threonine, ethanol, or
2-deoxyribose-5-phosphate (Ott et al 2000). Our
results suggest that acetaldehyde and ethanol produc-
tion bypass glucose. Although both R. mucilaginosa
and S. salivarius have the capacity to convert glucose to
pyruvate, RAST annotations of the two strains suggest
they do not have the genetic capability to convert
pyruvate to acetaldehyde by pyruvate decarboxylase
(E.C. 4.1.1.1; ﬁgure 2). Because the acetaldehyde and
ethanol we detected inR.mucilaginosa and S. salivarius
cultures are labeled in the presence of 2H2O but not
D-Glucose-13C6, they may share a common pathway
that involves the hydrolysis of 2H2O.
Based on genome annotations (ﬁgure 2), P. aerugi-
nosa, R. mucilaginosa, and S. salivarius are genetically
capable of converting ethanol to acetaldehyde by alco-
hol dehydrogenase (E.C. 1.1.1.1) (ﬁgure 2). S. salivar-
ius is also genetically capable of converting acetyl-CoA
Figure 2.A simpliﬁed schematic of pyruvatemetabolism. In red are the strains that have the listed genes in their genome.
Figure 3. 2,3-Butanedione, acetaldehyde, and ethanol production. (a) 2,3-butanedione, (b) acetaldehyde, and (c) ethanol unlabeled
and labeled concentrations in ppt.Media=average values of threemedia controls; Pa=P. aeruginosa; Rm=Rothiamucilaginosa;
Rm sup=spentmedium fromRothiamucilaginosa after 48 h of growth in THbroth supplementedwithD-Glucose-13C6; Ss=S.
salivarius; Ss sup=spentmedium from Streptococcus salivarius after 24 h of growth in THbroth supplementedwithD-Glucose-13C6.
Error bars represent standard deviation from themean. Shaded box represents conditionswhere only a single labeled isotopewas used
—D-Glucose-13C6. Unshaded areas display samples that were grown in the presence of 30%
2H2O andD-Glucose-
13C6.
5
J. Breath Res. 11 (2017) 017101 J Phan et al
to acetaldehyde by acetaldehyde dehydrogenase (E.C.
1.2.1.10) (ﬁgure 2). P. aeruginosa has the genetic cap-
ability to convert acetate or acetyl-CoA to acet-
aldehyde through enzymes aldehyde dehydrogenase
(E.C. 1.2.1.3) and acetaldehyde dehydrogenase (E.C.
1.2.1.10), respectively (ﬁgure 2). However, the cultur-
ing conditions did not lead P. aeruginosa to produce
signiﬁcant levels of acetaldehyde compared toR.muci-
laginosa or S. salivarius, and acetaldehyde and ethanol
were not labeled in the presence of 2H2O in the P. aer-
uginosa cultures.
Decreasing the pH of TH broth to pH 6.5 by add-
ing 100 mM potassium phosphate (ﬁgure 3) led to an
increase in growth and an even greater increase in the
production of 13C labeled 2,3-butanedione and unla-
beled acetaldehyde byR.mucilaginosa (ﬁgures 3(a) and
(b); OD600 of unbuffered cultures reached 0.73–0.76
while the OD600 of the pH 6.5 culture reached
2.48–2.55). S. salivarius, on the other hand, showed
higher 2,3-butanedione production in unbuffered
media compared to buffered pH 6.5 media. To verify
the presence and measure the concentrations of 2,3-
butandione in our samples, Voges–Proskauer assays
were performed on supernatants (supplementary
ﬁgure 1). The results were consistent with our gas
chromatography ﬁndings, in that we detected high
levels of 2,3-butanedione in theR.mucilaginosa super-
natant (ﬁgure 3(a) and supplementary ﬁgure 1).
Some limitations of studying pH dependent
microbial physiology include the additional nutrients
provided by the buffer (i.e., perhaps the phosphate
buffer provides phosphate which boosts growth); buf-
fered media may also eradicate micro-gradients rele-
vant in the CF lung. For example, R. mucilaginosa
produced more 2,3-butanedione in buffered pH 6.5
media while S. salivarius produced more when grown
in unbuffered media. S. salivarius cultured in unbuf-
feredmediamay includemicro-gradients that are even
more acidic than the buffered pH 6.5 media. Early
dairy literature demonstrated that as pH becomes
more acidic, Streptococci produce a higher yield of 2,3-
butanedione (diacetyl) (Michaelian et al 1938). With-
out the restriction of a buffered environment, S.
salivarius has the ability to further decrease the pH of
its micro-environment. Therefore, the local pH may
be much lower in an unbuffered condition than the
buffered pH 6.5 media, driving the physiology of a
subpopulation of cells.While buffers are useful to con-
trol the pH, especially for bulkmeasurements of VOCs
like those presented here, future studies using
pH sensitive dyes and imaging may allow observation
of the local spatial structure of interactions.
P. aeruginosa physiology is affected by exposure to
microbialmetabolites
P. aeruginosa is a dominant opportunistic pathogen in
CF and for this reason, to understand the polymicro-
bial community dynamics, it is essential to investigate
its role and interactions with other bacteria and their
metabolites. When P. aeruginosa was exposed to 2,3-
butanediol, lactic acid, and pyruvate in TH broth, not
only did we detect production of dimethyl sulﬁde
(DMS; ﬁgure 4(a)), we also detected production of
pyocyanin in the culture (ﬁgure 4(b)). DMS is a VOC
that is well studied in the marine food web and is
important in environmental sciences (Yoch 2002,
Carrión et al 2015); DMS has also been detected in the
breath of CF patients (Kamboures et al 2005), and P.
aeruginosa has been shown to produce DMS and
stimulate the growth of Aspergilles (Briard et al 2016).
The stable isotope labeled substrates (2H2O and
D-Glucose-13C6) did not lead to label incorporation
into DMS, potentially because glucose is not a
preferred carbon source for P. aeruginosa, and DMS
productionmay not depend on 2H2O exchange.
Pyocyanin is an active redox phenazine produced
by P. aeruginosa and found in the lungs of CF patients
(Mentel et al 2009, Hunter et al 2012, Glasser
et al 2014). Interestingly, DMS, pyocyanin production,
and growth are higher when P. aeruginosa is cultured
with 20 mM lactic acid (ﬁgures 4(a) and (b)). Lactic
acid both lowers pH and is a preferred carbon source
for P. aeruginosa, which could lead to better growth
and therefore increased production of DMS, pyocya-
nin and other metabolic products. In our conditions,
neitherR.mucilaginosa nor S. salivarius produceDMS.
Figure 4.P. aeruginosa (a)DMSand (b)pyocyanin production and (c)ﬁnal optical density reading. Pa=P. aeruginosa; Pa+bdl=P.
aeruginosa cultured in THbroth supplementedwith 20 mM2,3-butanediol; Pa+pyr=P. aeruginosa cultured in THbroth
supplementedwith 30 mMD-Glucose-13C6 and 30 mMpyruvate; Pa+la=P. aeruginosa cultured in THbroth supplementedwith
20 mM lactic acid. Error bars represent standard deviation from themean.
6
J. Breath Res. 11 (2017) 017101 J Phan et al
As such, we ﬁnd that among our strains, DMS produc-
tion is unique toP. aeruginosa.
Production of acetone and isoprene
Acetone and isoprene are the twomost abundant VOCs
detected in breath and canbe produced by either human
or bacterial cells. In our study, we ﬁnd that acetone was
detected as a labeled volatile in each of the media
controls and experimental conditions where 2H2O was
present (ﬁgure 5(a)). Therefore, the production of
acetone cannot be attributed to any of the strains
because of its presence in themedia controls. The use of
2H2O is not a reliable method for identifying metabolic
production of acetone and potentially other VOCs
including butanal, 2-methylpropanal, 3-methylbutanal,
2-methylbutanal, and 2-butanone (data not shown)
because the deuterium from the heavy water may be
exchangingwithhydrogens in themedia.
Isoprene levels were higher in both P. aeruginosa
and R. mucilaginosa cultures, and it was labeled when
P. aeruginosa and R. mucilaginosa were cultured in
media with 2H2O (ﬁgure 5(b)). Labeled isoprene was
not detected in the media controls or in P. aeruginosa
cultures lacking 2H2O, suggesting that label incor-
poration was due to bacterial metabolism. It is not
clear why isoprene levels were sometimes lower in R.
mucilaginosa and S. salivarius cultures. P. aeruginosa,
R.mucilaginosa, and S. salivarius share genes in the iso-
prenoid biosynthesis pathway, farnesyl diphosphate
synthase (E.C. 2.5.1.10) and geranylgeranyl pyropho-
sphate synthetase (E.C. 2.5.1.29). P. aeruginosa also
has several other genes involved in the isoprenoid
pathway, but neither P. aeruginosa nor R. mucilaginosa
have isoprene synthase (IspS, E.C. 4.2.3.27), the gene
required to convert dimethylallyl diphosphate
(DMAPP) to isoprene. There may be other mechan-
isms or pathways that allow P. aeruginosa and R. muci-
laginosa to produce isoprene. Other bacteria that have
been shown to produce isoprene are Bacillus subtilis
(Julsing et al 2007, Xue and Ahring 2011) and Escher-
ichia coli (Zhao et al 2011, Zurbriggen et al 2012).
Although isoprene was detected as labeled in R. muci-
laginosa control cultures, it was not detected in the
supernatants. Further investigation is needed to
understand the role of microbial metabolism in iso-
prene production.
Conclusions
Analysis of VOCs in breath often leads to the detection
of molecules that could be of human or microbial
origin. Ourmicrobial culture experiments using stable
isotope labeled substrates demonstrate that microbial
metabolism is responsible for the production of
several VOCs found in breath, including 2,3-butane-
dione, acetaldehyde, ethanol, and isoprene. GC analy-
sis and Voges–Proskauer test results have conﬁrmed
that clinical isolates R. mucilaginosa and S. salivarius
produce 2,3-butanedione, which has previously been
supported by metagenomics data (Whiteson
et al 2014). Acetaldehyde is an important molecule for
human health because it is a toxic carcinogenic
molecule that is produced by members of the oral
microbial community. Although it can be derived
from pyruvate, acetaldehyde production can start
from other substrates, including acetyl-CoA, acetate,
2-deoxyribose-5-phosphate, ethanol, and L-threonine
(Ott et al 2000). We found that our P. aeruginosa strain
produced DMS, which is more abundant when P.
aeruginosa is cultured in TH supplemented with lactic
acid. Finally, we found that labeled isoprene was
produced by P. aeruginosa and R. mucilaginosa.
Isoprene is one of the most abundant VOCs detected
in breath, but when compared to other studies that
measure concentrations of isoprene, our strains pro-
ducedmuch less thanwhat has been detected in breath
Figure 5.Acetone and isoprene production. (a)Acetone and (b) isoprene unlabeled and labeled concentrations in ppt.
Media=average values of threemedia controls; Pa=P. aeruginosa; Rm=R.mucilaginosa; Rm sup=spentmedium fromR.
mucilaginosa after 48 h of growth in THbroth supplementedwith 30 mMD-Glucose-13C6; Ss=S. salivarius; Ss sup=spent
medium from S. salivarius after 24 h of growth in THbroth supplementedwith 30 mMD-Glucose-13C6. Error bars represent standard
deviation from themean. Shaded box represents conditionswhere 30 mMD-Glucose-13C6was used. Unshaded areas display samples
that were grown in the presence of 30% 2H2Oor 30%
2H2O and 30 mMD-Glucose-
13C6.
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(King et al 2009, Khan et al 2013). This approach is
promising for teasing apart the interactions that affect
breath VOC production in human-associated micro-
bial communities. For example, future studies that
involve feeding stable isotope labeled substrates to one
type of bacteria, and cross-feeding the metabolic
products to another bacteria, could help us understand
metabolic interdependencies and their VOC signa-
tures in polymicrobial infections. As non-invasive
diagnoses are being developed, identifying the con-
tributing bacteria of an infection in CF is ideal for
employing more speciﬁc and timely treatments. Lab
results may take several days while results from breath
samples can be instantaneous. Studies focused on the
microbial origin of volatile molecules are critical for
using breath data for earlier diagnosis and targeted
treatments of infections.
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